Evidence map›Paper›PMID 26309859›Full record

ArticleInternational journal of ophthalmology2015

Phenotype of Usher syndrome type II assosiated with compound missense mutations of c.721 C>T and c.1969 C>T in MYO7A in a Chinese Usher syndrome family.

Wei Zhai, Xin Jin, Yan Gong, Ling-Hui Qu, Chen Zhao, Zhao-Hui Li

Open access · greenAbstract read
In one paragraph

Article in International journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei ZhaiDepartment of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China ; School of Medicine, Nan Kai University, Tianjin 300071, China ; Key Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Xin JinDepartment of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China.
Yan GongDepartment of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China.
Ling-Hui QuKey Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China ; Department of Ophthalmology, No.181 Hospital of Guilin, Guilin 541000, Guangxi Zhuang Autonomous Region, China.
Chen ZhaoKey Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Zhao-Hui LiDepartment of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo identify the pathogenic mutations in a Chinese pedigree affected with Usher syndrome type II (USH2).

methodsThe ophthalmic examinations and audiometric tests were performed to ascertain the phenotype of the family. To detect the genetic defect, exons of 103 known RDs -associated genes including 12 Usher syndrome (USH) genes of the proband were captured and sequencing analysis was performed to exclude known genetic defects and find potential pathogenic mutations. Subsequently, candidate mutations were validated in his pedigree and 100 normal controls using polymerase chain reaction (PCR) and Sanger sequencing.

resultsThe patient in the family occurred hearing loss (HL) and retinitis pigmentosa (RP) without vestibular dysfunction, which were consistent with standards of classification for USH2. He carried the compound heterozygous mutations, c.721 C>T and c.1969 C>T, in the MYO7A gene and the unaffected members carried only one of the two mutations. The mutations were not present in the 100 normal controls.

conclusionWe suggested that the compound heterozygous mutations of the MYO7A could lead to USH2, which had revealed distinguished clinical phenotypes associated with MYO7A and expanded the spectrum of clinical phenotypes of the MYO7A mutations.

Indexed as

mutationMYO7Anext-generation sequencingUsher syndrome

Identifiers

PMID26309859
PMCPMC4539639
OpenAlexW2396645431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.